Navigation Links
Verde Environmental Technologies Wins National Contract from NIDA/NIH for Development of Home Drug Deactivation System
Date:9/17/2013

MINNEAPOLIS, Sept. 17, 2013 /PRNewswire/ -- Verde Environmental Technologies of Burnsville, MN has been awarded a Phase 1 SBIR (Small Business Innovation Research) contract by the National Institute on Drug Abuse (NIDA), a branch of the National Institutes of Health (NIH) for the development of an inexpensive at home deactivation system for unwanted abusable psychoactive drugs. The contract (NIDA Ref. N43DA-13-4420) specifies the development of a system that would provide a simple way to safely inactivate and contain unwanted prescription drugs, thereby minimizing the potential for diversion or accidental exposure, and providing a safe and environmentally responsible way to properly dispose of pharmaceuticals.

"This is an important step for our company and for the general public," said Andrew Korey, PhD, Verde's CEO. "We believe that our at-source deactivation strategy for unused drugs will help combat the growing problems of abuse or diversion of drugs from the home," he added. Verde will develop a new product design in their Medsaway® 'single prescription' size format for disposal of unwanted controlled psychoactive prescriptions in pill, liquid, or transdermal dosage forms. As part of the contract, Verde will also conduct user testing, toxicity, and risk assessment evaluations.

The development of a new single prescription size of Medsaway could also expand the company's product offerings in pharmacies and could possibly be co-dispensed with prescriptions.

Disposal of unwanted pharmaceuticals has become a significant problem, causing environmental contamination of groundwater, as well as the significant risk of abuse or misuse of medications from the home. While community take back programs have been successful in accumulating tons of unwanted medications, such programs are expensive, take place infrequently, are inconvenient, and have been shown to only succeed in addressing a minor percentage of total unused drug accumulation. Verde has developed products that allow unwanted medication to be rendered safely inactivated and disposed of in an environmentally acceptable manner. Verde's proprietary Medsorb™ technology uses activated carbon, which is highly effective in adsorbing and firmly binding pharmaceuticals, rendering them inactive, and unrecoverable, and providing for an environmentally sound disposal method.

About Verde:
Verde is a privately held innovative organization, with manufacturing and operations based in Minnesota. Verde products include Medsaway systems (SP, Home, Professional, and XL) and Medsaway ContraPatch™ for safe inactivation of transdermal patches. More information about our products can be found at www.medsaway.com and www.contrapatch.com.

 


'/>"/>
SOURCE Verde Environmental Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma er stolt over at bakke op om HAE-dag :-) 2013 og vi hjælper HAE-patienter med at fylde verden med smil
2. Varian Medical Systems Publishes 2013 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
3. NASA Awards Environmental Engineering and Occupational Health Services Contract
4. MO BIO Laboratories, Inc. launches a new kit for isolation of viral nucleic acids from environmental samples
5. LodgeNet Healthcare, Siemens Partner To Deliver Bedside Environmental Controls For Maple Grove Hospital
6. B. Braun Joins National Health Organization Supporting Environmental Practices
7. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
8. International Isotopes Inc. Announces Nuclear Regulatory Commission Approval Of The Final Environmental Impact Statement For The Planned Depleted Uranium De-Conversion And Fluorine Extraction Processing Facility
9. SpineMark Corporation Partners with PhDx and Millennium Environmental to Create an ISO type Spine Protocol Management System
10. Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty
11. PendoTECH Single Use Process Sensors Reduce The Environmental Impact Of Critical Bioprocess Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):